Johnson SJ - Search Results

1

Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: a retrospective database analysis.

Lee LJ, Yu AP, Johnson SJ, Birnbaum HG, Atanasov P, Buesching DP, Jackson JA, Davidson JA. Lee LJ, et al. Among authors: johnson sj. Diabetes Res Clin Pract. 2010 Jan;87(1):108-16. doi: 10.1016/j.diabres.2009.09.023. Epub 2009 Nov 5. Diabetes Res Clin Pract. 2010. PMID: 19896233

2

Cost utility of adalimumab versus infliximab maintenance therapies in the United States for moderately to severely active Crohn's disease.

Yu AP, Johnson S, Wang ST, Atanasov P, Tang J, Wu E, Chao J, Mulani PM. Yu AP, et al. Pharmacoeconomics. 2009;27(7):609-21. doi: 10.2165/11312710-000000000-00000. Pharmacoeconomics. 2009. PMID: 19663531

3

Direct costs and survival of medicare beneficiaries with early and advanced Parkinson's disease.

Kaltenboeck A, Johnson SJ, Davis MR, Birnbaum HG, Carroll CA, Tarrants ML, Siderowf AD. Kaltenboeck A, et al. Among authors: johnson sj. Parkinsonism Relat Disord. 2012 May;18(4):321-6. doi: 10.1016/j.parkreldis.2011.11.015. Epub 2011 Dec 16. Parkinsonism Relat Disord. 2012. PMID: 22177623

4

Effects of care management and telehealth: a longitudinal analysis using medicare data.

Baker LC, Macaulay DS, Sorg RA, Diener MD, Johnson SJ, Birnbaum HG. Baker LC, et al. Among authors: johnson sj. J Am Geriatr Soc. 2013 Sep;61(9):1560-7. doi: 10.1111/jgs.12407. Epub 2013 Sep 3. J Am Geriatr Soc. 2013. PMID: 24028359

5

Costs of Parkinson's disease in a privately insured population.

Johnson SJ, Kaltenboeck A, Diener M, Birnbaum HG, Grubb E, Castelli-Haley J, Siderowf AD. Johnson SJ, et al. Pharmacoeconomics. 2013 Sep;31(9):799-806. doi: 10.1007/s40273-013-0075-0. Pharmacoeconomics. 2013. PMID: 23907717 Free PMC article.

6

An economic model of Parkinson's disease: implications for slowing progression in the United States.

Johnson SJ, Diener MD, Kaltenboeck A, Birnbaum HG, Siderowf AD. Johnson SJ, et al. Mov Disord. 2013 Mar;28(3):319-26. doi: 10.1002/mds.25328. Epub 2013 Feb 12. Mov Disord. 2013. PMID: 23404374

7

Cost-effectiveness of adalimumab for the maintenance of remission in patients with Crohn's disease.

Loftus EV Jr, Johnson SJ, Yu AP, Wu EQ, Chao J, Mulani PM. Loftus EV Jr, et al. Among authors: johnson sj. Eur J Gastroenterol Hepatol. 2009 Nov;21(11):1302-9. doi: 10.1097/MEG.0b013e32832a8d71. Eur J Gastroenterol Hepatol. 2009. PMID: 19465858 Clinical Trial.

8

Early retirement and income loss in patients with early and advanced Parkinson's disease.

Johnson S, Davis M, Kaltenboeck A, Birnbaum H, Grubb E, Tarrants M, Siderowf A. Johnson S, et al. Appl Health Econ Health Policy. 2011 Nov 1;9(6):367-76. doi: 10.2165/11596900-000000000-00000. Appl Health Econ Health Policy. 2011. PMID: 21919541

9

Integrated telehealth and care management program for Medicare beneficiaries with chronic disease linked to savings.

Baker LC, Johnson SJ, Macaulay D, Birnbaum H. Baker LC, et al. Among authors: johnson sj. Health Aff (Millwood). 2011 Sep;30(9):1689-97. doi: 10.1377/hlthaff.2011.0216. Health Aff (Millwood). 2011. PMID: 21900660

10

The impact of persistence with mirabegron usage vs switching to onabotulinumtoxinA on healthcare costs and resource utilization in patients with overactive bladder in the United States.

Ng DB, Espinosa R, Johnson SJ, Walker D, Gooch K. Ng DB, et al. Among authors: johnson sj. J Med Econ. 2017 Dec;20(12):1272-1280. doi: 10.1080/13696998.2017.1367300. Epub 2017 Sep 4. J Med Econ. 2017. PMID: 28805473 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters